Published in J Cancer Res Ther on September 01, 2009
Targeting the metabolic microenvironment of tumors. Adv Pharmacol (2012) 1.11
Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy. J Breast Cancer (2012) 1.11
Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer. Front Oncol (2014) 1.00
Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Sci Rep (2012) 0.92
Caloric restriction mimetic 2-deoxyglucose antagonizes doxorubicin-induced cardiomyocyte death by multiple mechanisms. J Biol Chem (2011) 0.92
The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance. Haematologica (2013) 0.90
Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication. World J Biol Chem (2015) 0.85
Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Res Notes (2015) 0.82
Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes. J Biol Inorg Chem (2014) 0.80
Emerging metabolic targets in the therapy of hematological malignancies. Biomed Res Int (2013) 0.79
2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells. PLoS One (2015) 0.78
Can short-term fasting protect against doxorubicin-induced cardiotoxicity? World J Biol Chem (2014) 0.76
2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner. Oxid Med Cell Longev (2017) 0.75
US breast cancer mortality trends in young women according to race. Cancer (2014) 2.07
Changes in sexual problems over time in women with and without early-stage breast cancer. Menopause (2010) 1.56
Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. J Surg Res (2012) 1.53
Predictors of primary breast abscesses and recurrence. World J Surg (2009) 1.51
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. J Clin Invest (2012) 1.49
Perioperative outcomes and complications of laparoscopic ventral hernia repair. Surgery (2005) 1.45
Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clin Cancer Res (2007) 1.45
Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol Cancer Res (2011) 1.42
IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. J Clin Invest (2013) 1.36
2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res (2003) 1.34
Patient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancer. J Surg Oncol (2009) 1.27
Disparities related to socioeconomic status and access to medical care remain in the United States among women who never had a mammogram. Cancer Causes Control (2003) 1.24
Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer. Am J Surg (2009) 1.16
Treatment and outcomes of patients with primary breast sarcoma. Am J Surg (2008) 1.07
Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat (2011) 1.02
A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer. Breast Cancer Res Treat (2010) 1.00
Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg (2008) 0.99
Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg (2010) 0.98
Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response. Ann Surg Oncol (2011) 0.97
Accuracy of perceived risk of recurrence among patients with early-stage breast cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.97
Metastatic disease to the breast: the Washington University experience. World J Surg Oncol (2007) 0.95
A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat (2009) 0.93
Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione. J Nucl Med (2012) 0.92
Assessment of cellular proliferation in tumors by PET using 18F-ISO-1. J Nucl Med (2013) 0.90
Breast cancer in elderly women (≥ 80 years): variation in standard of care? J Surg Oncol (2010) 0.89
The impact of breast MRI on surgical decision-making: are patients at risk for mastectomy? J Surg Oncol (2009) 0.88
Shared management of a rare necrotizing soft tissue infection of the breast. Breast J (2009) 0.87
Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomy. Am J Surg (2008) 0.83
Estrogen carcinogenesis: specific identification of estrogen-modified nucleobase in breast tissue from women. Chem Res Toxicol (2008) 0.81
Impact of multiple caregiving roles on elevated depressed mood in early-stage breast cancer patients and same-age controls. Breast Cancer Res Treat (2009) 0.81
Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection. Ann Surg Oncol (2012) 0.80
Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence. Am J Surg (2008) 0.80
Uneventful versus Successful Reconstruction and Outcome Pathways in Implant-Based Breast Reconstruction with Acellular Dermal Matrices. Plast Reconstr Surg (2016) 0.79
Are we overtreating papillomas diagnosed on core needle biopsy? Ann Surg Oncol (2010) 0.77
Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden. Ann Surg Oncol (2010) 0.76
Compromised margins following mastectomy for stage I-III invasive breast cancer. J Surg Res (2012) 0.75
Method of breast cancer presentation and depressed mood 1 year after diagnosis in women with locally advanced disease. Ann Surg Oncol (2009) 0.75